Most of Europe was in lockdown in April 2020 when a plane arrived in the Serbian capital bearing a well-timed gift from the People’s Republic of China. Inside was a Chinese invention called the Fire-Eye, a sophisticated portable lab that could detect coronavirus infections from tiny genetic fragments the pathogen leaves behind.

And that, as Serbians soon discovered, was the least of its capabilities.

The Fire-Eye excelled not only at cracking the genetic code for viruses, but also for humans, with machines that can decipher genetic instructions contained within the cells of every person on Earth, according to its Chinese inventors. In late 2021, with the pandemic still raging, Serbian officials announced they were working with a Chinese company to convert the lab into a permanent facility with plans to harvest and curate the entire genomes, or genetics blueprints, of Serbian citizens.

Serbia’s scientists were thrilled, and the country’s prime minister praised China for giving the Balkan country the “most advanced institute for precision medicine and genetics in the region.” Yet now, China’s Fire-Eye labs — scores of which were donated or sold to foreign countries during the pandemic — are attracting the attention of Western intelligence agencies amid growing unease about China’s intentions. Some analysts perceive China’s largesse as part of a global attempt to tap into new sources of highly valuable human DNA data in countries around the world.

That collection effort, underway for more than a decade, has included the acquisition of U.S. genetics companies as well as sophisticated hacking operations, U.S. and Western intelligence officials say. But more recently, it received an unexpected boost from the coronavirus pandemic, which created opportunities for Chinese companies and institutes to distribute gene-sequencing machines and build partnerships for genetic research in places where Beijing previously had little or no access, the officials said.

Amid the pandemic, Fire-Eye labs would proliferate quickly, spreading to four continents and more than 20 countries, from Canada and Latvia to Saudi Arabia, and from Ethiopia and South Africa to Australia. Several, like the one in Belgrade, now function as permanent genetic-testing centers.

“Covid-19,” said one senior U.S. intelligence analyst who closely tracks China’s biotechnology sector, “was the door.”

China’s global reach

A spokesman for the Chinese Embassy in Washington rejected any suggestion that Chinese companies had improperly gained access to genetic data. The spokesman, Liu Pengyu, said the Fire-Eye labs helped many countries battle a dangerous pandemic and continue to play a vital role in screening for cancer and other diseases. BGI Group, the Shenzhen-based company that makes Fire-Eye labs, said it has no access to genetic information collected by the lab it helped create in Serbia.

But U.S. officials note that BGI was picked by Beijing to build and operate the China National GeneBank, a vast and growing government-owned repository that now includes genetic data drawn from millions of people around the world. The Pentagon last year officially listed BGI as one of several “Chinese military companies” operating in the United States, and a 2021 U.S. intelligence assessment linked the company to the Beijing-directed global effort to obtain even more human DNA, including from the United States.

The U.S. government also has blacklisted Chinese subsidiaries of BGI for allegedly helping analyze genetic material gathered inside China to assist government crackdowns on the country’s ethnic and religious minorities. BGI, in a statement to The Washington Post, characterized the U.S. actions against the company as “impacted by misinformation” and said BGI Group “does not condone and would never be involved in any human rights abuses.”

“None of BGI Group is state-owned or state controlled, and all of BGI Group’s services and research are provided for civilian and scientific purposes,” the company said.

Beijing’s drive to sweep up DNA from across the planet has occasionally stirred controversy, particularly after a 2021 Reuters series about aspects of the project. Chinese academics and military scientists have also attracted attention by debating the feasibility of creating biological weapons that might someday target populations based on their genes. Genetic-based weapons are regarded by experts as a distant prospect, at best, and some of the discussion appears to have been prompted by official paranoia about whether the United States and other countries are exploring such weapons.

U.S. intelligence officials believe China’s global effort is mostly about beating the West economically, not militarily. There is no public evidence that Chinese companies have used foreign DNA for reasons other than scientific research.

China has announced plans to become the world’s leader in biotechnology by 2035, and it regards genetic information — sometimes called “the new gold” — as a crucial ingredient in a scientific revolution that could produce thousands of new drugs and cures. If it wins the technology race, China stands to gain significant economic and strategic leverage against its chief rival, the United States, said Anna Puglisi, formerly the U.S. intelligence community’s chief national counterintelligence officer for East Asia.

  • RIPandTERROR@sh.itjust.works
    link
    fedilink
    English
    arrow-up
    7
    ·
    1 year ago

    Well up until now, collecting my genetic material has mostly been my S/O’s job, but if China wants in on it we probably can make room for a third.